$11.23
+0.02 (+0.18%)
Open$11.28
Previous Close$11.21
Day High$11.28
Day Low$11.08
52W High$17.20
52W Low$9.50
Volume—
Avg Volume113.1K
Market Cap358.00M
P/E Ratio51.97
EPS$0.14
SectorN/A
Analyst Ratings
Strong Buy
5 analysts
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 63.22M | 66.33M | 66.97M |
| Net Income | 7.61M | 7.36M | 6.38M |
| Profit Margin | 12.0% | 11.1% | 9.5% |
| EBITDA | 9.86M | 10.37M | 9.59M |
| Free Cash Flow | 5.27M | 5.23M | 4.88M |
| Rev Growth | +23.9% | +15.1% | +6.4% |
| Debt/Equity | 0.30 | 0.36 | 0.34 |
N/A Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| EMAT | Evolution Metals & Technolog | $3.03 | +34.07% | — | 1.75B |
| PICS | Pics Nv | $11.49 | +0.70% | 6.8 | 1.56B |
| DMII | Drugs Made In America Acquis | $10.13 | +0.10% | 75.0 | 644.01M |
| CCCX | Churchill Capital Corp X-A | $10.08 | -5.62% | — | 2.32B |
| BEAG | Bold Eagle Acquisition Cor-A | $10.75 | +0.55% | 35.3 | 335.10M |
| CEPF | Cantor Equity Partners-Cl A | $10.39 | +0.14% | 57.7 | 593.79M |